Pontus Duner

Malmoe, M 20502, Sweden

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications

Tumor Progression, Parallel Mechanisms and Therapeutic Targets.

Tumor Progression, Parallel Mechanisms and Therapeutic Targets.

Journal: Cancers
Published: June 24, 2026

Increased ADORA1 expression in pancreatic islets coincides with insulin secretory defects in human type 2 diabetes.

Increased ADORA1 expression in pancreatic islets coincides with insulin secretory defects in human type 2 diabetes.

Journal: The Journal of biological chemistry
Published: May 08, 2026

Author Correction: Dysregulation of MMP2-dependent TGF-ß2 activation impairs fibrous cap formation in type 2 diabetes-associated atherosclerosis.

Author Correction: Dysregulation of MMP2-dependent TGF-ß2 activation impairs fibrous cap formation in type 2 diabetes-associated atherosclerosis.

Journal: Nature communications
Published: February 12, 2025

A New IL-6-Inducing Mechanism in Cancer with New Therapeutic Possibilities.

A New IL-6-Inducing Mechanism in Cancer with New Therapeutic Possibilities.

Journal: Cancers
Published: September 10, 2024

Identification of an osteopontin-derived peptide that binds neuropilin-1 and activates vascular repair responses and angiogenesis.

Identification of an osteopontin-derived peptide that binds neuropilin-1 and activates vascular repair responses and angiogenesis.

Journal: Pharmacological research
Published: December 28, 2023

Dysregulation of MMP2-dependent TGF-ß2 activation impairs fibrous cap formation in type 2 diabetes-associated atherosclerosis.

Dysregulation of MMP2-dependent TGF-ß2 activation impairs fibrous cap formation in type 2 diabetes-associated atherosclerosis.

Journal: Nature communications
Published: June 23, 2023

Ablation of GPR56 Causes β-Cell Dysfunction by ATP Loss through Mistargeting of Mitochondrial VDAC1 to the Plasma Membrane.

Ablation of GPR56 Causes β-Cell Dysfunction by ATP Loss through Mistargeting of Mitochondrial VDAC1 to the Plasma Membrane.

Journal: Biomolecules
Published: January 25, 2023

Transforming growth factor-β2 is associated with atherosclerotic plaque stability and lower risk for cardiovascular events.

Transforming growth factor-β2 is associated with atherosclerotic plaque stability and lower risk for cardiovascular events.

Journal: Cardiovascular research
Published: August 21, 2022

Antibodies against apoB100 peptide 210 inhibit atherosclerosis in apoE-/- mice.

Antibodies against apoB100 peptide 210 inhibit atherosclerosis in apoE-/- mice.

Journal: Scientific reports
Published: November 19, 2020

COVID-19 and Possible Pharmacological Preventive Options.

COVID-19 and Possible Pharmacological Preventive Options.

Journal: Journal of clinical medicine research
Published: October 27, 2020

The proteoglycan mimecan is associated with carotid plaque vulnerability and increased risk of future cardiovascular death.

The proteoglycan mimecan is associated with carotid plaque vulnerability and increased risk of future cardiovascular death.

Journal: Atherosclerosis
Published: February 19, 2020

Inhibitory effect of UDP-glucose on cAMP generation and insulin secretion.

Inhibitory effect of UDP-glucose on cAMP generation and insulin secretion.

Journal: The Journal of biological chemistry
Published: February 07, 2020
Showing 1-12 of 43

Last Updated: 09/26/2026